This is so undervalued at the moment. Once the perception out there sinks in there will be a scramble for the shares. I was purchasing my first shares at 18-20c two years ago when we thought we were close to receiving CE Mark approval. The SP ran to 27.5c.
Move forward 2 years we are now cashed up (albeit there has been dilution), we have significantly de-risked the company from a clinical perspective and financial and we are on the cusp of earning revenue at the back end of this calendar year. Two brokers have our intrinsic SP at around 40c.
We currently sit at a cheap 14c - i have been accumulating where I can. This is set to RUN and run hard soon.
Ann: OSL to present at Finance News Network Investor Session, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |